Contrary to the results obtained from the APP/PS1 mouse model, the intranasal treatment using constitutively active Rac1 rescued spine deficits in in 6.5-month-old 3xTg-AD mice (Borin et al., 2018). The gene discussed is RAC1; the disease is Alzheimer disease.